Last reviewed · How we verify
Elzsa film-coated tablet
Elzsa film-coated tablet is a Small molecule drug developed by PT Sydna Farma. It is currently in Phase 1 development. Also known as: 2 mg cyproterone acetate + 0.035 mg ethinylestradiol.
At a glance
| Generic name | Elzsa film-coated tablet |
|---|---|
| Also known as | 2 mg cyproterone acetate + 0.035 mg ethinylestradiol |
| Sponsor | PT Sydna Farma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Elzsa film-coated tablet CI brief — competitive landscape report
- Elzsa film-coated tablet updates RSS · CI watch RSS
- PT Sydna Farma portfolio CI
Frequently asked questions about Elzsa film-coated tablet
What is Elzsa film-coated tablet?
Elzsa film-coated tablet is a Small molecule drug developed by PT Sydna Farma.
Who makes Elzsa film-coated tablet?
Elzsa film-coated tablet is developed by PT Sydna Farma (see full PT Sydna Farma pipeline at /company/pt-sydna-farma).
Is Elzsa film-coated tablet also known as anything else?
Elzsa film-coated tablet is also known as 2 mg cyproterone acetate + 0.035 mg ethinylestradiol.
What development phase is Elzsa film-coated tablet in?
Elzsa film-coated tablet is in Phase 1.
Related
- Manufacturer: PT Sydna Farma — full pipeline
- Also known as: 2 mg cyproterone acetate + 0.035 mg ethinylestradiol
- Compare: Elzsa film-coated tablet vs similar drugs
- Pricing: Elzsa film-coated tablet cost, discount & access